Martin J. Payne
February 27, 2023
Martin Payne has more than 25 years of experience in executive and board positions in a mix of private and public, global enterprises. Martin’s current board positions, in addition to Astraius, are with Health Care Services Acquisition Company (Nasdaq: HCARU) and the privately held HRGi Holdings Inc. Martin has served in board leadership positions at MedX, Comprehensive Clinical Solutions and HRGi, where he led strategic and operational transformation efforts, including the business combination of three diverse healthcare services companies now operating as HRGi Holdings, Inc., and the successful, over-subscribed, IPO launch of HCARU, raising over $330 million. In addition to multiple entrepreneurial successes, Martin was formerly with Catalyst Health Solutions (formerly Nasdaq: CHSI), leading the highly value-accretive M&A transactions and integrations of HospiScript, IPS, Total Script, InPharmative, Future Scripts, Walgreens Health Initiatives, and RegenceRx, during which time Catalyst’s stock price rose fourfold. Prior to his tenure with Catalyst, Martin served in executive leadership roles at Coventry Health Care, Hanger Orthopedic Group, and United Health Group. He ran European marketing and sales for American Electric Power, and built and managed pharmaceutical manufacturing plants in the UK. Martin started his career in the Royal Navy as a helicopter pilot, and is a graduate of the University of Essex.